Fig 8
Distribution of Predicted for each of (a) EQ-5D-5L and (b) EQ-5D-3L after Cross Validation Models (50 % Holdout Sample): LDVMM. a. EQ-5D-3L. b. EQ-5D-5L
Fig 8 | Health and Quality of Life Outcomes
Distribution of Predicted for each of (a) EQ-5D-5L and (b) EQ-5D-3L after Cross Validation Models (50 % Holdout Sample): LDVMM. a. EQ-5D-3L. b. EQ-5D-5L